P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.29 MYR Market Closed
Market Cap: 1.9B MYR

Net Margin

1.1%
Current
Improving
by 6.6%
vs 3-y average of -5.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
1.1%
=
Net Income
43.2m
/
Revenue
3.9B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
1.1%
=
Net Income
MYR43.2m
/
Revenue
3.9B

Peer Comparison

Country Company Market Cap Net
Margin
MY
Pharmaniaga Bhd
KLSE:PHARMA
1.9B MYR
Loading...
US
Mckesson Corp
NYSE:MCK
102.5B USD
Loading...
US
Cencora Inc
NYSE:COR
69.2B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
67.7B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
50.2B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.5B AUD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.2B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
63.6B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.9B USD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
66B HKD
Loading...

Market Distribution

In line with most companies in Malaysia
Percentile
37th
Based on 1 168 companies
37th percentile
1.1%
Low
-53 603.4% — -0.8%
Typical Range
-0.8% — 9.6%
High
9.6% — 15 766%
Distribution Statistics
Malaysia
Min -53 603.4%
30th Percentile -0.8%
Median 3.9%
70th Percentile 9.6%
Max 15 766%

Pharmaniaga Bhd
Glance View

Market Cap
1.9B MYR
Industry
Health Care

Pharmaniaga Bhd.operates as an investment holding company. The company is headquartered in Shah Alam, Selangor. The firm is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy. The Company’s segment includes Logistics and distribution, Manufacturing, and Indonesia. The Logistics and distribution segment is engaged in the distribution, trading, and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment is involved in manufacturing of pharmaceutical products in Malaysia. The Indonesia segment is engaged manufacturing and distribution of pharmaceutical and medical products in Indonesia. Its subsidiaries include Idaman Pharma Manufacturing Sdn. Bhd., Pharmaniaga Manufacturing Berhad, Pharmaniaga LifeScience Sdn. Bhd., Pharmaniaga Logistics Sdn. Bhd., and Pharmaniaga Marketing Sdn. Bhd.

PHARMA Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
1.1%
=
Net Income
43.2m
/
Revenue
3.9B
What is Pharmaniaga Bhd's current Net Margin?

The current Net Margin for Pharmaniaga Bhd is 1.1%, which is above its 3-year median of -5.5%.

How has Net Margin changed over time?

Over the last 3 years, Pharmaniaga Bhd’s Net Margin has decreased from 3.6% to 1.1%. During this period, it reached a low of -19.8% on Sep 30, 2023 and a high of 3.6% on Sep 30, 2022.

Back to Top